Thomas Andrew Crockett is CEO at KalVista Pharmaceuticals, Inc. (KALV). They have made 22 open-market trades across 1 company since 2019, most recently 2024-02-20.
CIK 0001690920
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 22 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KALV | 236,091 | $6.4M |
Shares reported on the most recent Form 4, priced at the 2024-02-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KALV | SELL | 2024-02-20 | 2024-02-21 | $14.11 | $702K | +7.0% | -9.6% | -11.4% |
| KALV | SELL | 2024-02-14 | 2024-02-16 | $15.01 | $1.8M | -6.5% | -17.9% | -17.3% |
| KALV | SELL | 2024-02-01 | 2024-02-05 | $16.22 | $162K | -6.1% | -8.5% | -22.8% |
| KALV | SELL · 10b5-1 | 2023-12-27 | 2023-12-28 | $12.02 | $361K | +4.7% | +18.0% | -8.8% |
| KALV | SELL | 2023-11-20 | 2023-11-21 | $8.23 | $244K | +11.4% | +41.2% | +72.9% |
| KALV | SELL | 2023-08-18 | 2023-08-21 | $10.73 | $319K | -1.1% | -13.3% | -25.2% |
| KALV | SELL | 2023-05-18 | 2023-05-19 | $10.14 | $114K | -3.2% | -7.5% | +5.0% |
| KALV | SELL | 2023-02-17 | 2023-02-23 | $7.66 | $51K | -1.7% | -15.4% | +32.9% |
| KALV | SELL | 2022-11-18 | 2022-11-21 | $5.44 | $10K | +3.7% | +5.0% | +50.5% |
| KALV | SELL · 10b5-1 | 2022-09-02 | 2022-09-07 | $17.01 | $22K | -2.3% | -67.8% | -66.9% |
| KALV | SELL | 2022-08-17 | 2022-08-19 | $14.96 | $27K | +9.8% | +0.0% | -64.2% |
| KALV | SELL | 2022-03-09 | 2022-03-11 | $17.07 | $171K | +6.3% | -9.0% | -44.0% |
| KALV | SELL | 2021-10-01 | 2021-10-04 | $17.18 | $172K | +2.5% | +6.7% | -18.5% |
| KALV | SELL | 2021-07-01 | 2021-07-02 | $24.22 | $379K | -5.4% | -11.9% | -24.8% |
| KALV | SELL · 10b5-1 | 2021-06-17 | 2021-06-22 | $30.04 | $32K | -10.8% | -19.5% | -31.7% |
| KALV | SELL | 2021-06-09 | 2021-06-11 | $30.05 | $537K | -5.8% | -20.7% | -25.8% |
| KALV | SELL | 2021-04-01 | 2021-04-05 | $27.44 | $274K | -10.0% | -11.0% | -18.0% |
| KALV | SELL | 2021-02-23 | 2021-02-25 | $33.57 | $631K | -5.6% | -20.7% | -22.2% |
| KALV | SELL | 2021-01-04 | 2021-01-06 | $18.16 | $348K | +1.9% | -8.7% | +60.8% |
| KALV | SELL | 2020-10-20 | 2020-10-22 | $18.02 | $1.3M | +8.5% | +16.7% | +3.8% |
| KALV | SELL · 10b5-1 | 2020-10-16 | 2020-10-20 | $17.01 | $21K | -0.6% | +6.9% | -2.0% |
| KALV | SELL · 10b5-1 | 2020-02-05 | 2020-02-07 | $17.05 | $3K | -9.1% | -22.8% | -35.7% |
| KALV | SELL · 10b5-1 | 2019-12-20 | 2019-12-26 | $17.02 | $39K | -6.6% | -5.6% | -58.4% |
| KALV | SELL | 2019-12-12 | 2019-12-16 | $17.06 | $131K | -1.5% | +2.0% | -56.6% |
| KALV | SELL | 2019-07-15 | 2019-07-17 | $17.04 | $170K | -3.0% | -5.9% | -38.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.